BTG Pactual Asset Management US LLC Has $1.86 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

BTG Pactual Asset Management US LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,673 shares of the healthcare conglomerate’s stock after buying an additional 609 shares during the quarter. BTG Pactual Asset Management US LLC’s holdings in UnitedHealth Group were worth $1,858,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $25,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $599.10 on Friday. The stock’s 50-day moving average is $512.87 and its 200-day moving average is $542.03. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $548.00 billion, a P/E ratio of 38.65, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Analyst Ratings Changes

A number of research firms have recently weighed in on UNH. Truist Financial lifted their target price on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a report on Friday. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Twenty-one investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $632.85.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.